Patient's preferences and shared decision-making: Considering environmental aspects in head lice treatment

被引:1
|
作者
Garcia-Blasco, Camino [1 ]
Domingo-Echaburu, Saioa [2 ]
Orive, Gorka [1 ,3 ,4 ,5 ]
Lertxundi, Unax [6 ]
机构
[1] Univ Basque Country UPV EHU, Sch Pharm, Lab Pharmaceut, NanoBioCel Grp, Paseo Univ 7, Vitoria-Gasteiz 01006, Spain
[2] Debagoiena Integrated Hlth Org, Osakidetza Basque Hlth Serv, Pharm Serv, Nafarroa Hiribidea 16, Arrasate Mondragon 20500, Gipuzkoa, Spain
[3] Biomed Res Networking Ctr Bioengn Biomat & Nanomed, CIBER, BBN, Vitoria-Gasteiz, Spain
[4] Univ Inst Regenerat Med & Oral Implantol, UIRMI UPV EHU, Fdn Eduardo Anitua, Vitoria, Spain
[5] NanoBioCel Res Grp, Bioaraba, Vitoria-Gasteiz, Spain
[6] Araba Psychiat Hosp, Araba Mental Hlth Network, Osakidetza Basque Hlth Serv, Bioaraba Hlth Res Inst,Pharm Serv, c-Alava 43, Vitoria 01006, Alava, Spain
来源
关键词
Permethrin; Head lice; One health; Rational use of medicines;
D O I
10.1016/j.scp.2023.101142
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
One of the most commonly used drugs to treat head lice is permethrin. This drug is also frequently used in veterinary medicine as a pet parasiticide, while its use as a plant protection agent is now restricted because of its ecotoxicity. This substance has been included as a priority substance in the proposal of the European Water Framework Directive and consequently, Environmental Quality Standard (EQS) have been established. Available literature shows that domestic treatment of head lice seems to be the main source of permethrin to municipal wastewater treatment plants (WWTP), while washing pet's hair could also be a contributing factor. Concentration in WWTP effluents are frequently > EQS for different environmental matrices. Besides, studies have shown very high concentrations in sludge, which is worrying considering its use as a fertilizer in agri-culture. The development of resistance of lice to permethrin has driven the development of drugs with different mode of action, such as dimethicone. This drug has shown comparable efficacy to permethrin without its environmental consequences. Moreover, non-pharmacological methods should be preferred when possible. As awareness about the environmental impact of medicines grows, these aspects may become a crucial part of patient's preferences in shared decision-making. Although the ecotoxicological impact of pharmaceuticals is still rarely considered by healthcare professionals or patients when using drugs, the One Health philosophy could also be applied when it comes to treating head lice. We can no longer consider a rational use of medicines if we continue to neglect their environmental impacts.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] DECISION-MAKING IN SUPPORT - PATIENT PERCEPTIONS AND PREFERENCES
    COULTON, CJ
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 : S51 - S54
  • [42] Combining patient preferences with expected treatment outcomes to inform decision-making
    Schuler M.S.
    Hatfield L.A.
    Health Services and Outcomes Research Methodology, 2017, 17 (2) : 144 - 174
  • [43] Patient's Perspective of Shared Decision-Making in Rheumatoid Arthritis Treatment: A Grounded Theory Exploration
    Oliveira, Isabela Viana
    do Nascimento, Mariana Martins Gonzaga
    Rezende, Cristiane de Paula
    Neves, Carina de Morais
    Silva, Hagabo Mathyell
    Cesar, Ana Luiza Mourawad
    Ramalho-de-Oliveira, Djenane Ramalho-de-Oliveira
    QUALITATIVE REPORT, 2023, 28 (07): : 1902 - 1926
  • [44] Shared Decision-making in Head and Neck Surgery A Review
    Forner, David
    Noel, Christopher W.
    Shuman, Andrew G.
    Hong, Paul
    Corsten, Martin
    Rac, Valeria E.
    Pieterse, Arwen H.
    Goldstein, David
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2020, 146 (09) : 839 - 844
  • [45] Shared decision making: Does a physician's decision-making style affect patient participation in treatment choices for primary immunodeficiency?
    Lamb, Christopher C.
    Wang, Yunmei
    Lyytinen, Kalle
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2019, 25 (06) : 1102 - 1110
  • [46] STRUCTURED SHARED DECISION-MAKING MODEL TO GAIN PATIENT'S PARTICIPATION
    Asakura, Yuki
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [47] What's Not Being Shared in Shared Decision-Making?
    Stark, Meredith
    Fins, Joseph J.
    HASTINGS CENTER REPORT, 2013, 43 (04) : 13 - 16
  • [48] SHARED DECISION-MAKING PREFERENCES AND PAIN CHARACTERIZATION IN PATIENTS WITH CANCER
    Brant, Jeannine
    Stricker, Carrie
    Wujcik, Deborah
    Petok, Alison
    Sih-Meynier, Regina
    Dudley, William
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [49] Antibiotic and shared decision-making preferences among adolescents in Malaysia
    Ngadimon, Irma Wati
    Islahudin, Farida
    Hatah, Ernieda
    Shah, Noraida Mohamed
    Makmor-Bakry, Mohd
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 665 - 673
  • [50] Shared decision-making preferences of people with severe mental illness
    Adams, Jared R.
    Drake, Robert E.
    Wolford, George L.
    PSYCHIATRIC SERVICES, 2007, 58 (09) : 1219 - 1221